Methenamine mandelate: Difference between revisions
| (2 intermediate revisions by the same user not shown) | |||
| Line 5: | Line 5: | ||
{{CMG}}; {{AE}} {{MM}} | {{CMG}}; {{AE}} {{MM}} | ||
==Overview== | ==Overview== | ||
Methenamine mandelate, USP, a urinary antibacterial agent, is the chemical combination of mandelic acid with methenamine. Methenamine mandelate, USP is available for oral use as film-coated tablets. Methenamine mandelate, USP is indicated for the suppression or elimination of bacteriuria associated with pyelonephritis, cystitis, and other chronic urinary tract infections.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = METHENAMINE MANDELATE TABLET [EDENBRIDGE PHARMACEUTICALS, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cc299e8a-cf9a-4dc6-b6e6-972141e59296 | publisher = | date = | accessdate}}</ref> | |||
==Category== | ==Category== | ||
Urinary anti-infective | |||
==US Brand Names== | ==US Brand Names== | ||
| Line 16: | Line 17: | ||
''' [[Methenamine mandelate description|Description]]''' | ''' [[Methenamine mandelate description|Description]]''' | ||
'''| [[Methenamine mandelate clinical pharmacology|Clinical Pharmacology]]''' | '''| [[Methenamine mandelate clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[Methenamine mandelate indications and usage|Indications and Usage]]''' | '''| [[Methenamine mandelate indications and usage|Indications and Usage]]''' | ||
'''| [[Methenamine mandelate contraindications|Contraindications]]''' | '''| [[Methenamine mandelate contraindications|Contraindications]]''' | ||
'''| [[Methenamine mandelate warnings and precautions|Warnings and Precautions]]''' | '''| [[Methenamine mandelate warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[Methenamine mandelate adverse reactions|Adverse Reactions]]''' | '''| [[Methenamine mandelate adverse reactions|Adverse Reactions]]''' | ||
'''| [[Methenamine mandelate dosage and administration|Dosage and Administration]]''' | '''| [[Methenamine mandelate dosage and administration|Dosage and Administration]]''' | ||
'''| [[Methenamine mandelate how supplied|How Supplied]]''' | '''| [[Methenamine mandelate how supplied|How Supplied]]''' | ||
Latest revision as of 09:21, 9 January 2014
| Methenamine mandelate |
|---|
| METHENAMINE MANDELATE® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Dosage and Administration |
| How Supplied |
| Labels and Packages |
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Methenamine mandelate, USP, a urinary antibacterial agent, is the chemical combination of mandelic acid with methenamine. Methenamine mandelate, USP is available for oral use as film-coated tablets. Methenamine mandelate, USP is indicated for the suppression or elimination of bacteriuria associated with pyelonephritis, cystitis, and other chronic urinary tract infections.[1]
Category
Urinary anti-infective
US Brand Names
METHENAMINE MANDELATE®
FDA Package Insert
Description | Clinical Pharmacology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Dosage and Administration | How Supplied | Labels and Packages
Mechanism of Action
An acid urine is essential for antibacterial action, with maximum efficacy occurring at pH 5.5 or less. In an acid urine, mandelic acid exerts its antibacterial action and also contributes to the acidification of the urine.[1]
References
- ↑ 1.0 1.1 "METHENAMINE MANDELATE TABLET [EDENBRIDGE PHARMACEUTICALS, LLC]". Text " accessdate" ignored (help)